Skip to Content

Desloratadine Pregnancy and Breastfeeding Warnings

Desloratadine is also known as: Aerius, Clarinex, Clarinex Reditabs, Neoclarityn

Medically reviewed on Apr 13, 2018

Desloratadine Pregnancy Warnings

Desloratadine has been assigned to pregnancy category C by the FDA. Animal studies have failed to reveal evidence of teratogenicity. There are no controlled data in human pregnancy. Desloratadine is only recommended for use during pregnancy when benefit outweighs risk.

See references

Desloratadine Breastfeeding Warnings

Desloratadine is excreted into human milk. The effects in the nursing infant are unknown. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Clarinex (desloratadine)." Schering Corporation, Kenilworth, NJ.

References for breastfeeding information

  1. "Product Information. Clarinex (desloratadine)." Schering Corporation, Kenilworth, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide